Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
2.
Eur J Intern Med ; 88: 89-95, 2021 06.
Article in English | MEDLINE | ID: mdl-33888392

ABSTRACT

BACKGROUND: Adrenomedullin (AM) is a vasoactive peptide mostly secreted by endothelial cells with an important role in preserving endothelial integrity.  The relationship between AM and hereditary hemorrhagic telangiectasia (HHT) is unknown. We aimed to compare the serum levels and tissue expression of AM between HHT patients and controls. METHODS: Serum AM levels were measured by radioimmunoassay and compared between control and HHT groups. AM levels were also compared among HHT subgroups according to clinical characteristics. The single nucleotide polymorphism (SNP) rs4910118 was assessed by restriction analysis and sequencing. AM immunohistochemistry was performed on biopsies of cutaneous telangiectasia from eight HHT patients and on the healthy skin from five patients in the control group. RESULTS: Forty-five HHT patients and 50 healthy controls were included, mean age (SD) was 50.7 (14.9) years and 46.4 (9.9) years (p = 0.102), respectively. HHT patients were mostly female (60% vs 38%, p = 0.032). Median [Q1-Q3] serum AM levels were 68.3 [58.1-80.6] pg/mL in the HHT group and 47.7 [43.2-53.8] pg/mL in controls (p<0.001), with an optimal AM cut-off according to Youden's J statistic of 55.32 pg/mL (J:0.729). Serum AM levels were similar in the HHT subgroups. No patient with HHT had the SNP rs4910118. AM immunoreactivity was found with high intensity in the abnormal blood vessels of HHT biopsies. CONCLUSIONS: We detected higher AM serum levels and tissue expression in patients with HHT than in healthy controls. The role of AM in HHT, and whether AM may constitute a novel biomarker and therapeutic target, needs further investigation.


Subject(s)
Telangiectasia, Hereditary Hemorrhagic , Adrenomedullin/genetics , Biomarkers , Endothelial Cells , Female , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Telangiectasia, Hereditary Hemorrhagic/genetics
3.
Transpl Infect Dis ; 13(5): 507-14, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21323828

ABSTRACT

Disseminated adiaspiromycosis is a rare infection that is sometimes associated with immunocompromised situations. We report the case of a patient, infected with human immunodeficiency virus and receiving highly active antiretroviral therapy, who had a liver transplant for hepatocellular carcinoma. The patient presented skin and pulmonary lesions due to adiaspiromycosis during immunosuppressive therapy. A review of >60 cases in the literature shows that adiaspiromycosis is a rare infection and Emmonsia is a dimorphic fungus that is difficult to grow. It should be considered a possible diagnosis in case of fungal infection and pulmonary granulomatosis. We should be aware of emerging adiaspiromycosis in patients with risk factors of immunosuppression, particularly transplant recipients. In these patients in particular, liposomal amphotericin B therapy should be considered.


Subject(s)
Chrysosporium/isolation & purification , HIV Infections/complications , Liver Transplantation/adverse effects , Mycoses/etiology , Fatal Outcome , Humans , Male , Middle Aged
4.
Rev. clín. esp. (Ed. impr.) ; 210(11): 550-555, dic. 2010. tab, ilus
Article in Spanish | IBECS | ID: ibc-82898

ABSTRACT

Objetivos. Aunque el lupus pernio (LP) es la lesión cutánea más característica de la sarcoidosis crónica, en nuestro país se han comunicado muy pocos casos. El objetivo del estudio fue revisar la frecuencia y características clínicas de los pacientes con LP en una serie amplia de pacientes con sarcoidosis. Métodos. Revisión retrospectiva de la frecuencia y características de los pacientes diagnosticados de LP de la serie de sarcoidosis de nuestro centro durante un periodo de 35 años. Resultados. De 507 pacientes con sarcoidosis, 8 (1,6%) presentaron LP. La edad media fue de 42 años. En 6 casos el LP fue la forma de presentación de la sarcoidosis. Cinco pacientes mostraron afectación de la piel nasal y un caso presentó afectación severa de la mucosa nasal. Todos los pacientes fueron tratados con antimaláricos, 4 con corticoides, 2 con láser o con combinaciones con otros fármacos. Resultados. Ningún paciente con afectación cutánea nasal presentó remisión del LP. Conclusiones. El LP es poco frecuente en las formas clínicas de la sarcoidosis de nuestro país. La afectación cutánea nasal no responde al tratamiento. La reciente introducción del infliximab puede representar un avance en el tratamiento del LP(AU)


Objectives. Although lupus pernio (LP) is the most characteristic cutaneous lesion of chronic sarcoidosis, only a few cases have been reported in our country. The aim of this study was to review the frequency and clinical characteristics of patients with LP in a large series of patients with sarcoidosis. Methods. A retrospective review of the frequency and characteristics of patients diagnosed as having LP from the series of sarcoidosis of our institution for a period of 35 years was performed. Results. Eight (1.6%) out of 507 patients with sarcoidosis were diagnosed of LP. Mean age was 42 years. In 6 patients, LP was the presentation form of sarcoidosis. Five patients had involvement of the nasal skin and one patient severe involvement of the nasal mucosa. All the patients were treated with antimalarial drugs, 4 with oral corticosteroids, 2 with laser therapy, or with combinations with other drugs. None of the patient having nasal skin involvement showed remission of LP. Conclusions. LP is a rare clinical form of sarcoidosis in our country. No treatment is effective for nasal skin involvement. The recent introduction of infliximab may represent an advance in the treatment of LP(AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Chilblains/complications , Chilblains/diagnosis , Sarcoidosis/complications , Sarcoidosis/diagnosis , Chloroquine/therapeutic use , Hydroxychloroquine/therapeutic use , Adrenal Cortex Hormones/therapeutic use , Retrospective Studies , Tuberculin , Tuberculin Test , Kveim Test , Electrocardiography , Methotrexate/therapeutic use , Minocycline/therapeutic use
5.
Rev Clin Esp ; 210(11): 550-5, 2010 Dec.
Article in Spanish | MEDLINE | ID: mdl-20979994

ABSTRACT

OBJECTIVES: Although lupus pernio (LP) is the most characteristic cutaneous lesion of chronic sarcoidosis, only a few cases have been reported in our country. The aim of this study was to review the frequency and clinical characteristics of patients with LP in a large series of patients with sarcoidosis. METHODS: A retrospective review of the frequency and characteristics of patients diagnosed as having LP from the series of sarcoidosis of our institution for a period of 35 years was performed. RESULTS: Eight (1.6%) out of 507 patients with sarcoidosis were diagnosed of LP. Mean age was 42 years. In 6 patients, LP was the presentation form of sarcoidosis. Five patients had involvement of the nasal skin and one patient severe involvement of the nasal mucosa. All the patients were treated with antimalarial drugs, 4 with oral corticosteroids, 2 with laser therapy, or with combinations with other drugs. None of the patient having nasal skin involvement showed remission of LP. CONCLUSIONS: LP is a rare clinical form of sarcoidosis in our country. No treatment is effective for nasal skin involvement. The recent introduction of infliximab may represent an advance in the treatment of LP.


Subject(s)
Sarcoidosis , Skin Diseases , Adult , Chronic Disease , Female , Humans , Male , Middle Aged , Sarcoidosis/diagnosis , Sarcoidosis/therapy , Skin Diseases/diagnosis , Skin Diseases/therapy
7.
Clin Exp Dermatol ; 32(6): 696-8, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17725666

ABSTRACT

Eccrine angiomatous hamartoma (EAH) is a lesion that tends to appear as a plaque or nodular single lesion that may be painful and/or hyperhidrotic. Histopathologically, EAH is manifested by lobules of mature eccrine glands and ducts closely associated with well-differentiated, thin-walled blood vessels. Rarely, EAH can present as a macular hyperhidrotic lesion following a segmental distribution.


Subject(s)
Eccrine Glands/pathology , Hamartoma/pathology , Hyperhidrosis/etiology , Port-Wine Stain/pathology , Sweat Gland Diseases/pathology , Adolescent , Fever/etiology , Hamartoma/complications , Humans , Male , Port-Wine Stain/complications , Sweat Gland Diseases/complications
12.
Br J Dermatol ; 141(3): 541-3, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10583064

ABSTRACT

Pyoderma gangrenosum is a neutrophilic dermatosis of unknown aetiology. Visceral involvement by pyoderma gangrenosum is rare, the lung being the most frequent site of extracutaneous disease. We describe a 73-year-old man with pyoderma gangrenosum and chronic myelomonocytic leukaemia in whom aseptic hepatosplenic abscesses and bony lesions were associated.


Subject(s)
Bone Diseases/complications , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Liver Abscess/complications , Pyoderma Gangrenosum/complications , Pyoderma Gangrenosum/pathology , Splenic Diseases/complications , Abscess/complications , Abscess/drug therapy , Aged , Anti-Inflammatory Agents/therapeutic use , Bone Diseases/drug therapy , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Liver Abscess/drug therapy , Male , Prednisone/therapeutic use , Pyoderma Gangrenosum/drug therapy , Splenic Diseases/drug therapy
13.
Clin Exp Dermatol ; 23(3): 119-20, 1998 May.
Article in English | MEDLINE | ID: mdl-9861740

ABSTRACT

Carcinoma of the prostate gland is the second most frequent malignancy in males, accounting for 17% of cancer in men; between a third and one-half of these patients will have distant metastases at onset, but rarely cutaneous. We now report a case of prostatic adenocarcinoma with such metastases involving the right nipple and periareolar skin, overlying an area of hormone-induced gynaecomastia.


Subject(s)
Adenocarcinoma/secondary , Gynecomastia/complications , Prostatic Neoplasms/pathology , Skin Neoplasms/secondary , Aged , Antineoplastic Agents, Hormonal/adverse effects , Estramustine/adverse effects , Fatal Outcome , Gynecomastia/chemically induced , Humans , Male
14.
Arch Dermatol ; 134(3): 309-15, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9521029

ABSTRACT

OBJECTIVE: To analyze risk factors for systemic involvement and long-term course in leukocytoclastic vasculitis. DESIGN: A clinicopathological study of 160 patients with leukocytoclastic vasculitis followed up for at least 3 years. Univariate and multivariate analysis were conducted by logistic regression methods. SETTING: The Bellvitge Hospital, a referral center in Barcelona, Spain. PATIENTS: One hundred sixty patients with cutaneous leukocytoclastic vasculitis. Patients in the categories cutaneous/systemic vasculitis and acute/chronic cutaneous vasculitis were selected for comparative analysis. MAIN OUTCOME MEASURES: Clinical, laboratory, and histopathological findings. RESULTS: Of 89 females and 71 males, aged 14 to 89 years, systemic involvement was documented in 20% of cases. Perinuclear-staining antineutrophil cytoplasmic autoantibodies were found in 21% of patients and cryoglobulins in 25.4%. Of the patients, 1.9% died of systemic vasculitis. The average duration of cutaneous lesions was 27.9 months. In 67.2%, a cause or associated condition was identified. Of the skin specimens, 59.6% showed vasculitis limited to superficial dermal vessels. Direct immunofluorescence was positive in 84.3% of cases. In the multivariate analysis, paresthesia, fever, and absence of painful lesions were found to be risk factors for systemic involvement. Cryoglobulins, arthralgia, and normal temperature were risk factors for chronic cutaneous disease. CONCLUSION: Our results identify prognostic factors in leukocytoclastic vasculitis and may provide some aid in the management of this heterogeneous group of patients.


Subject(s)
Skin Diseases, Vascular/pathology , Vasculitis, Leukocytoclastic, Cutaneous/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Antibodies, Antineutrophil Cytoplasmic/analysis , Autoantibodies/analysis , Female , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Prognosis , Renal Insufficiency/complications , Risk Factors , Skin/pathology , Skin Diseases, Vascular/complications , Skin Diseases, Vascular/immunology , Vasculitis, Leukocytoclastic, Cutaneous/complications , Vasculitis, Leukocytoclastic, Cutaneous/immunology
18.
Arch Dermatol ; 133(4): 443-50, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9126007

ABSTRACT

OBJECTIVES: To investigate the sequential expression of adhesion molecules on endothelium and inflammatory cells in cutaneous leukocytoclastic vasculitis, and the relation of these adhesive molecules with clinical and histologic variables. DESIGN: An immunohistochemical analysis (streptavidin-biotin-peroxidase technique) of 42 vasculitic lesions of up to 96 hours was performed using a panel of monoclonal antibodies specific for different adhesion molecules. Twenty normal skin samples and 3 perilesional specimens served as control samples. A clinical protocol was also performed, and patients were followed up for 1 to 5 years. SETTING: A clinicopathologic research unit of a university hospital. PATIENTS: Forty-two patients, 21 women and 21 men, aged 22 to 79 years, with cutaneous leukocytoclastic vasculitis. INTERVENTIONS: Three skin biopsy specimens of vasculitic lesions from each patient were obtained for histopathologic examination on paraffin, direct immunofluorescence, and immunohistochemical analysis on cryostatic tissue sections. MAIN OUTCOME MEASURES: The histologic characteristics and the immunohistochemical-stained specimens were evaluated by 3 independent investigators, using a semiquantitative method. RESULTS: Increased endothelial expression of very late activation antigen-1, HLA-DR, and intercellular adhesion molecule-1 was observed. The induction of E-selectin expression was more marked in recent lesions (P < .001) and correlated with the proportion of infiltrating neutrophils (P = .03). Endothelial expression of vascular cell adhesion molecule-1 was restricted to developed lesions. Most infiltrating cells were neutrophils expressing Mac-1. In 1 patient, lymphocyte function associated antigen-1 expression was also up-regulated. No significant increase in CD3, CD8, or CD71 immunoreactivity was found. An up-regulation of perivascular cells expressing HLA-DR and vascular cell adhesion molecule-1 was observed in vasculitic lesions. This cellular staining correlated with long-term evolution of the disease (P = .04). CONCLUSIONS: Adhesion molecules are sequentially upregulated in cutaneous leukocytoclastic vasculitis. The results of this study support the possible involvement of E-selectin in mediating recruitment of neutrophils expressing Mac-1.


Subject(s)
Cell Adhesion Molecules/biosynthesis , Endothelium/immunology , Vasculitis, Leukocytoclastic, Cutaneous/immunology , Adult , Aged , Endothelium/cytology , Female , Humans , Immunohistochemistry , Male , Middle Aged , Vasculitis, Leukocytoclastic, Cutaneous/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...